Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer for Phase II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00002525
What this trial is testing

Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 859
Testing effectiveness (Phase 2)UnknownNCT04759664
What this trial is testing

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Who this might be right for
EGFRI Induced Acneiform Lesions
Lutris Pharma Ltd. 117
Testing effectiveness (Phase 2)Ended earlyNCT00423150
What this trial is testing

Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)

Who this might be right for
Colorectal NeoplasmHead and Neck NeoplasmCarcinoma, Non-Small-Cell Lung+1 more
Merck Sharp & Dohme LLC 86
Large-scale testing (Phase 3)Study completedNCT00002968
What this trial is testing

Edrecolomab in Treating Patients With Stage II Colon Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonSignet Ring Adenocarcinoma of the ColonStage IIA Colon Cancer+2 more
National Cancer Institute (NCI) 2,100
Large-scale testing (Phase 3)Study completedNCT00112918
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 3,451
Large-scale testing (Phase 3)Study completedNCT00025090
What this trial is testing

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

Who this might be right for
Anal Cancer
University College London (UCL) Cancer Institute 600
Not applicableStudy completedNCT01703585
What this trial is testing

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

Who this might be right for
Colorectal CancerBreast CancerGynecological Cancer+3 more
University Health Network, Toronto 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04440735
What this trial is testing

DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerColorectal Cancer
Kahr Medical 125
Testing effectiveness (Phase 2)UnknownNCT01237665
What this trial is testing

IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer

Who this might be right for
Rectal Cancer
Ottawa Hospital Research Institute 15
Testing effectiveness (Phase 2)Ended earlyNCT05733611
What this trial is testing

RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Who this might be right for
Refractory Metastatic Colorectal CancerpMMRMSS
Replimune, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT03547999
What this trial is testing

A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC

Who this might be right for
Metastatic Colorectal Cancer
Patrick Boland 17
Testing effectiveness (Phase 2)Ended earlyNCT00642746
What this trial is testing

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
OHSU Knight Cancer Institute 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07585279
What this trial is testing

A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)Liposomal IrinotecanSecond-Line
Hebei Medical University Fourth Hospital 408
Testing effectiveness (Phase 2)Ended earlyNCT01856322
What this trial is testing

Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerLiver MetastasisColorectal Adenocarcinoma
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT00353457
What this trial is testing

Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Rectal Cancer
Abramson Cancer Center at Penn Medicine 6
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Temporarily pausedNCT07011550
What this trial is testing

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Who this might be right for
Microsatellite-stable Colorectal CancerStandard of CareNivolumab+1 more
M.D. Anderson Cancer Center 7
Not applicableStudy completedNCT05495308
What this trial is testing

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more
Hospital San Carlos, Madrid 4
Not applicableLooking for participantsNCT06477991
What this trial is testing

The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.

Who this might be right for
Clinical Complete Response Rate With Negative MRD
Yunnan Cancer Hospital 22
Next Page